Teva Pharmaceutical Industries Ltd SEC filings TEVA
Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2026 | Sep 16, 2026 |
| 8-K |
Current report
Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 8-A12B/A | Filing | Sep 14, 2026 | — |
| 25-NSE | Delisting notice | Sep 14, 2026 | — |
| 424B5 | Prospectus supplement | Sep 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 11, 2026 | Sep 9, 2026 |
| FWP | Free writing prospectus | Sep 10, 2026 | — |
| FWP | Free writing prospectus | Sep 10, 2026 | — |
| 424B5 | Prospectus supplement | Sep 8, 2026 | — |
| 8-K |
Current report
Other events
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Change to shareholder rights
|
Sep 3, 2026 | Aug 31, 2026 |
| F-6 POS | Filing | Jul 29, 2026 | — |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2026 | May 28, 2026 |
| 10-Q | Quarterly report | Apr 29, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 29, 2026 | Apr 29, 2026 |
| DEFA14A | Additional proxy material | Mar 31, 2026 | — |
| ARS | Annual report to shareholders | Mar 31, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Mar 31, 2026 | May 28, 2026 |
| 10-K | Annual report | Feb 3, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 11, 2025 | Dec 10, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | Jun 5, 2025 |
| SD | Specialized disclosure (conflict minerals) | Jun 2, 2025 | — |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 22, 2025 | May 20, 2025 |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| FWP | Free writing prospectus | May 20, 2025 | — |
| 424B5 | Prospectus supplement | May 19, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| UPLOAD | Letter from the SEC | Apr 28, 2025 | — |
| CORRESP | Letter to the SEC | Apr 14, 2025 | — |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 9, 2025 | Jun 5, 2025 |
| UPLOAD | Letter from the SEC | Apr 7, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 7, 2025 | — |
| 10-K | Annual report | Feb 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 12, 2024 | Nov 5, 2024 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 10-Q | Quarterly report | Jul 31, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 31, 2024 | Jul 31, 2024 |
| 8-K |
Current report
Material agreement
|
Jun 25, 2024 | Jun 23, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 15, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 18, 2024 | Apr 18, 2024 |
| UPLOAD | Letter from the SEC | Apr 17, 2024 | — |
| DEFA14A | Additional proxy material | Apr 16, 2024 | — |
| ARS | Annual report to shareholders | Apr 16, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 16, 2024 | Jun 6, 2024 |
| CORRESP | Letter to the SEC | Apr 8, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2024 | — |
| 10-K | Annual report | Feb 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 31, 2024 | Jan 31, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2023 | Oct 4, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 28, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 24, 2023 | Aug 21, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2023 | Aug 1, 2023 |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 8, 2023 | Jun 8, 2023 |
| DEFA14A | Additional proxy material | May 24, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 24, 2023 | — |
| 8-K |
Current report
Officer or director change
|
May 11, 2023 | May 8, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 10, 2023 | May 10, 2023 |
| ARS | Annual report to shareholders | Apr 19, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 19, 2023 | — |
| DEF 14A | Proxy statement | Apr 19, 2023 | — |
| 8-K |
Current report
Material agreement, New debt
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 3, 2023 | Mar 1, 2023 |
| 424B5 | Prospectus supplement | Mar 3, 2023 | — |
| FWP | Free writing prospectus | Mar 1, 2023 | — |
| 424B5 | Prospectus supplement | Feb 27, 2023 | — |
| 10-K | Annual report | Feb 10, 2023 | Dec 31, 2022 |
| F-6EF | Filing | Feb 8, 2023 | — |
| 8-K |
Current report
Results of operations
|
Feb 8, 2023 | Feb 8, 2023 |
| UPLOAD | Letter from the SEC | Dec 21, 2022 | — |
| CORRESP | Letter to the SEC | Dec 20, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2022 | Nov 18, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| CORRESP | Letter to the SEC | Oct 26, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2022 | — |
| 10-Q | Quarterly report | Jul 27, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Jul 26, 2022 | Jul 26, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 23, 2022 | Jun 23, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 25, 2022 | — |
| 10-Q | Quarterly report | May 3, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | Jun 23, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 15, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2022 | Feb 24, 2022 |
| 10-K | Annual report | Feb 9, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 9, 2022 | Feb 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 24, 2021 | Nov 22, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 10, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2021 | Nov 2, 2021 |
| 424B5 | Prospectus supplement | Nov 4, 2021 | — |
| FWP | Free writing prospectus | Nov 2, 2021 | — |
| 8-K |
Current report
Other events
|
Nov 2, 2021 | Nov 2, 2021 |
| 424B3 | Prospectus | Oct 27, 2021 | — |
| S-3ASR | Automatic shelf registration | Oct 27, 2021 | — |
| 10-Q | Quarterly report | Oct 27, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2021 | Aug 26, 2021 |
| 10-Q | Quarterly report | Jul 28, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2021 | Jul 21, 2021 |
| 8-K |
Current report
Officer or director change
|
Jul 6, 2021 | Jul 2, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2021 | Jun 14, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 20, 2021 | — |
| 10-Q | Quarterly report | Apr 28, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2021 | — |
| DEF 14A | Proxy statement | Apr 21, 2021 | Jun 14, 2021 |
| UPLOAD | Letter from the SEC | Apr 21, 2021 | — |
| CORRESP | Letter to the SEC | Apr 15, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2021 | — |
| 10-K | Annual report | Feb 10, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2021 | Feb 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2021 | Jan 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 25, 2021 | Jan 21, 2021 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| EFFECT | Filing | Aug 17, 2020 | — |
| 424B3 | Prospectus | Aug 17, 2020 | — |
| SD | Specialized disclosure (conflict minerals) | Aug 14, 2020 | — |
| CORRESP | Letter to the SEC | Aug 13, 2020 | — |
| CORRESP | Letter to the SEC | Aug 13, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Aug 6, 2020 | Aug 4, 2020 |
| S-4 | Registration for a merger or exchange | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 POS | Filing | Aug 5, 2020 | — |
| S-8 | Employee stock plan registration | Aug 5, 2020 | — |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| UPLOAD | Letter from the SEC | Jul 15, 2020 | — |
| CORRESP | Letter to the SEC | Jun 19, 2020 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2020 | Jun 9, 2020 |
| DEFA14A | Additional proxy material | May 26, 2020 | — |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEF 14A | Proxy statement | Apr 22, 2020 | Jun 9, 2020 |
| CORRESP | Letter to the SEC | Apr 17, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2020 | — |
| PRE 14A | Preliminary proxy statement | Mar 19, 2020 | Jun 9, 2020 |
| 10-K | Annual report | Feb 21, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2020 | Feb 12, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Nov 25, 2019 | Nov 25, 2019 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2019 | Oct 21, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2019 | Oct 2, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2019 | Jun 11, 2019 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2019 | — |
| 10-Q | Quarterly report | May 2, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 2, 2019 | May 2, 2019 |
| DEFA14A | Additional proxy material | Apr 16, 2019 | — |
| DEF 14A | Proxy statement | Apr 16, 2019 | Jun 11, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
Apr 10, 2019 | Apr 8, 2019 |
| 10-K | Annual report | Feb 19, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Feb 13, 2019 | Feb 13, 2019 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Dec 14, 2018 | Dec 14, 2018 |
| 8-K |
Current report
Change to shareholder rights
|
Dec 4, 2018 | Dec 4, 2018 |
| EFFECT | Filing | Dec 3, 2018 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 26, 2018 | Nov 26, 2018 |
| F-6 | Filing | Nov 13, 2018 | — |
| 10-Q | Quarterly report | Nov 1, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2018 | Nov 1, 2018 |
| 10-Q | Quarterly report | Aug 2, 2018 | Jun 30, 2018 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TEVA (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Large accelerated filer
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.